Parkinson's Disease Trial, Recruiting NCT07402928 Sponsor: Danish Research Centre for Magnetic Resonance Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07402928
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Parkinson's disease:

  • People who are at least 35 years old
  • People who have been formally diagnosed with Parkinson's disease according to established medical diagnostic guidelines
  • People whose Parkinson's disease mainly affects movement and muscle stiffness (rather than tremor as the main feature)
  • People who have been on a stable Parkinson's medication routine for at least 4 weeks, without major side effects such as involuntary movements or unpredictable "on-off" fluctuations
  • People who have signed a consent form agreeing to take part

For healthy volunteers (people without Parkinson's disease):

  • People who are at least 35 years old
  • People who have signed a consent form agreeing to take part

Who may not be able to join:

For people with Parkinson's disease:

  • Women of childbearing age who are pregnant, or who are not using contraception
  • People who are currently breastfeeding
  • People who have a history of any other neurological or psychiatric condition, apart from depression
  • People with claustrophobia, a pacemaker, implanted electronic devices, metal in the body, or any other reason they cannot safely have an MRI scan
  • People currently receiving advanced Parkinson's treatments, such as a duodopa pump or apomorphine pen
  • People who regularly take antipsychotic medications or certain nerve-related medications such as pregabalin or gabapentin
  • People with severe depression, based on a standard depression scoring tool (confirm with trial site)
  • People who do not wish to be told about any unexpected health-related findings that may arise during the study

For healthy volunteers:

  • Women of childbearing age who are pregnant, or who are not using contraception
  • People who are currently breastfeeding
  • People who have a history of any neurological or psychiatric condition, apart from depression
  • People with claustrophobia, a pacemaker, implanted electronic devices, metal in the body, or any other reason they cannot safely have an MRI scan
  • People who regularly take antipsychotic medications or certain nerve-related medications such as pregabalin or gabapentin
  • People with severe depression, based on a standard depression scoring tool (confirm with trial site)
  • People who do not wish to be told about any unexpected health-related findings that may arise during the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David Meder, PhD, Danish Research Centre for Magnetic Resonance (DRCMR), Hvidovre Hospital

Phone: 004529892696

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Danish Research Centre for Magnetic Resonance
Registry
ClinicalTrials.gov
Start date
2 June 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Topographic distribution of the degree of optimism or pessimism

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov